News
New study identifies an epigenetic signature associated to the rare genetic disorder GATA2 deficiency
The results show that patients with this disorder have abnormal genetic and epigenetic patterns, which could contribute to the development of diverse clinical manifestations, such as compromise the ability of blood cell production.
M Carolina Florian new ICREA Research Professor
Dra. M Carolina Florian, group leader at IDIBELL, has been appointed as an ICREA Research Professor. ICREA, the Catalan Institution for Research and Advanced Studies, offers permanent, tenured positions to the most talented and extraordinary scientists and academics to come and work in Catalonia. Over the years these positions have become a synonym for global academic excellence.
The first meeting of the Working Groups of the project GENERATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS FROM HAPLO-SELECTED CORD BLOOD SAMPLES (HAPLO-IPS)
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
A drug that boosts the regeneration of stem cells extends life expectancy in mice
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
It starts a project to create a collaborative network for the generation of stem cells compatible with a high percentage of the population
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
A study describes a new way to generate insulin-producing cells
Researchers from the Karolinska Institute in Sweden, in collaboration with Meritxell Rovira from IDIBELL, the P-CMRC, and the UB show that a recently identified molecule stimulates the formation of new insulin-producing cells in zebrafish and in mammalian tissues.
New mural in tribute to Dr. Anna Veiga
The mural is located in the CEIP Pinedo of Valencia and is a piece by the artist Marta Lapeña. This is the mural number 27 of the project with which the UPV and Las Naves are filling the Valencian educational centers with science and art, in feminine.
Begins the exchange program between IDIBELL and SZBL
It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.
Joint SZBL-IDIBELL PhD Exchange Program (2022 Call)
SZBL and IDIBELL launch their joint PhD Exchange Program call for 2022, with the aim of fostering collaboration in research between both institutions in the field of Regenerative Medicine and providing exceptional training in the field for graduated students by promoting mobility and allowing interaction with outstanding researchers.
The generation of a stem cell-derived neurofibroma model opens the door to new treatments development
Neurofibromas are tumors of the peripheral nervous system, which develop in people with a hereditary disease, and they are the main cause of death among those people.
Nanopolymer treatment prevents the formation of protein aggregates in neurons derived from Parkinson’s patients
One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.
Pancreatic beta-cell boost in mice paves way for future diabetes treatments
A research team from IDIBELL, CRG and UB has uncovered the role of a gene that is critical to boosting the number of insulin-producing cells during the early development of the pancreas. The findings could bolster diabetes research efforts and eventually lead to new replacement therapies for the disease.
Identified an early neuronal dysfunction in Parkinson’s that could help early diagnosis
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
CRISPR/Cas9 Human Embryo Genome Editing for the Study of Genes Related to Early Embryo Development
Dr. Anna Veiga is leading the project CRISPR/Cas9 human embryo genome editing (GE) for the study of genes related to early embryo development.
P-CMR[C] researchers define a new mechanism of aging in a bone marrow stem cell in women
To equilibrate the gene expression between XX females and XY males, one of female X chromosomes is inactivated. Researchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.
The group led by Dr. Alessandra Giorgetti receives a grant from the GESMD to study myelodysplastic syndrome
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
The team led by Dr. M. Carolina Florian receives a European grant of 2 million euros to study bone marrow rejuvenation
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
The P-CMR[C] organize an open session to present the results of the EoI Call for Collaborative Projects
We are organizing a scientific session with all the awarded projects, where all participant groups will present the research performed and the collaborations born thanks to these projects.
Jordi Guiu, the new group leader of the Regenerative Medicine Program
Jordi Guiu joins to P-CMR[C] as group leader and opens the Cell Plasticity and Regeneration group
Artificial intelligence, a new tool against leukemia
Dr. M. Carolina Florian (Program of Regenerative Medicine, IDIBELL, Spain) and Prof. Medhanie Mulaw (Ulm University, Germany) will receive more than 800.000 euros from the “La Caixa” Foundation to apply deep learning to investigate leukemia in the elderly
P-CMR[C] scientists find a compound that extends life span in mice
Regenerative medicine scientists at IDIBELL in collaboration with partners at Ulm University (Germany) have demonstrated that inhibition of Cdc42 with CASIN can pharmacologically extend lifespan.
The P-CMR[C] launches its website
The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C]), which aims to group research on stem cells in Catalonia, now has its own space in internet.
Anna Veiga will study embryonic development through human embryo genome edition
The team of Dra. Anna Veiga, who leads the study, will optimize the CRISPR/Cas9 technique to modify the human embryo genome
Ángel Raya and Antonella Consiglio awarded with the City of Barcelona Award
Two researchers from IDIBELL and P-CMR[C], have been awarded in this edition of the City of Barcelona Awards, in the Life Sciences category
State of ‘hibernation’ keeps haematopoietic stem cells young
An international team led by researchers from Ulm and Barcelona has now discovered special niches in the bone marrow that protect haematopoietic stem cells from ageing processes
The New Program for Regenerative Medicine in Catalonia Has Officially Launched
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
